Dongya Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dongya Chen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Zhaolin Zhang
Department of Gastroenterology Hangzhou Red Cross Hospital Hangzhou China
2 shared publicationsDilong Fang
Department of Vascular Surgery and Thyroid & Breast Surgery Hangzhou Red Cross Hospital Hangzhou China
1 shared publicationFang Chen
Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, Hangzhou, China
1 shared publicationFeng Pan
Department of Gastroenterology Hangzhou Red Cross Hospital Hangzhou China
1 shared publication- Feng Pan
Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, Hangzhou, China
1 shared publication Hong Xu
Department of Gastroenterology and Hepatology, Hangzhou Red Cross Hospital, Hangzhou, China
1 shared publication
Latest Publications
- 25 September 2026
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (11) , 3422-3432
Biliary Microbiota and Bile Acid Remodeling in Common Bile Duct Stone Patients: A Pilot Multi‐Omics Analysis of ERCP‐Acquired Human Bile
Background: Gallstone disease is increasingly recognized as involving host–microbe–metabolite interactions. Although biliary microbial communities have been detected in biliary obstruction, their relationship with bile acid remodeling in common bile duct (CBD) stone disease remains unclear. Methods: ERCP‐acquired bile samples from 25 patients, including 12 with CBD stones and 13 patients with non‐stone pancreatobiliary diseases, including malignant and benign conditions, were analyzed using 16S rRNA sequencing and targeted bile acid metabolomics. Between‐group comparisons and exploratory microbe–bile acid correlation analyses were performed. Results: Bile samples contained detectable microbial communities dominated by Pseudomonadota and Bacillota . Alpha diversity and overall community structure were comparable between groups, with no significant beta‐diversity separation (PERMANOVA R 2 = 0.0483, p = 0.259). No taxa remained significant after multiple‐testing correction, although several genera showed nominal between‐group differences. Targeted metabolomics showed only mild separation between groups. TUDCA/THDCA and UDCA were higher in the CBD stone group at the nominal p < 0.05 level, whereas 12‐O‐CDCA showed a nonsignificant increasing trend; none remained significant after FDR correction. Exploratory multi‐omics analysis suggested nominal microbe–bile acid associations, but these correlations were also not significant after FDR correction. Conclusion: This pilot multi‐omics study identified detectable biliary microbial communities and exploratory bile acid remodeling trends in ERCP‐acquired bile from patients with CBD stones. However, key taxonomic, metabolomic, and association findings did not survive multiple‐testing correction and should be interpreted as hypothesis‐generating observations requiring validation in larger, well‐characterized cohorts.
- 25 September 2026
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (11) , 3422-3432
Biliary Microbiota and Bile Acid Remodeling in Common Bile Duct Stone Patients: A Pilot Multi‐Omics Analysis of ERCP‐Acquired Human Bile
Background: Gallstone disease is increasingly recognized as involving host–microbe–metabolite interactions. Although biliary microbial communities have been detected in biliary obstruction, their relationship with bile acid remodeling in common bile duct (CBD) stone disease remains unclear. Methods: ERCP‐acquired bile samples from 25 patients, including 12 with CBD stones and 13 patients with non‐stone pancreatobiliary diseases, including malignant and benign conditions, were analyzed using 16S rRNA sequencing and targeted bile acid metabolomics. Between‐group comparisons and exploratory microbe–bile acid correlation analyses were performed. Results: Bile samples contained detectable microbial communities dominated by Pseudomonadota and Bacillota . Alpha diversity and overall community structure were comparable between groups, with no significant beta‐diversity separation (PERMANOVA R 2 = 0.0483, p = 0.259). No taxa remained significant after multiple‐testing correction, although several genera showed nominal between‐group differences. Targeted metabolomics showed only mild separation between groups. TUDCA/THDCA and UDCA were higher in the CBD stone group at the nominal p < 0.05 level, whereas 12‐O‐CDCA showed a nonsignificant increasing trend; none remained significant after FDR correction. Exploratory multi‐omics analysis suggested nominal microbe–bile acid associations, but these correlations were also not significant after FDR correction. Conclusion: This pilot multi‐omics study identified detectable biliary microbial communities and exploratory bile acid remodeling trends in ERCP‐acquired bile from patients with CBD stones. However, key taxonomic, metabolomic, and association findings did not survive multiple‐testing correction and should be interpreted as hypothesis‐generating observations requiring validation in larger, well‐characterized cohorts.
- Open Access
- 30 April 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (2) , 256-266
Associations between Metabolic Syndrome Indicators and Colon Polyps: A Mendelian Randomization Study
Background: While observational studies have suggested a potential link between metabolic syndrome (MetS) and an increased risk of colon polyps, the causal nature of this association remains uncertain. This study used a two-sample Mendelian randomization (MR) approach to evaluate the relationship between MetS and colon polyps.Methods: A two-sample MR analysis was performed using data on MetS, its indicators, and colon polyps obtained from publicly available genome-wide association studies in the Integrative Epidemiology Unit (IEU) and MAGIC databases. Outliers were removed using Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), followed by MR calculations and false discovery rate (FDR) correction. The primary analysis was conducted with the inverse variance-weighted (IVW) method.Results: The IVW results indicated no association between hypertension, hyperlipidemia, or diabetes and the risk of colon polyps. High-density lipoprotein cholesterol (HDL-C) (P=0.005), 2-hour glucose (P=0.004), glycated hemoglobin A1c (P=0.004), and the ratio of omega-6 to omega-3 fatty acids (P<0.001) were negatively associated with colon polyps. Conversely, body mass index (BMI) (P<0.001), body fat percentage (P=0.002), waist-to-hip ratio adjusted for BMI (P=0.001), total cholesterol (TC) (P=0.002), triglycerides (TG) (P<0.001), and both omega-3 (P<0.001) and omega-6 fatty acid levels (P=0.02) were positively associated with colon polyps. The relationships between these metabolic indicators and colon polyps remained significant after FDR correction.Conclusion: Obesity-related traits, TC, and TG may increase the risk of colon polyps, while HDL-C may have a protective effect.
- 30 April 2026
- Published by Korean Endocrine Society in Endocrinology and Metabolism
- Vol. 41 (2) , 256-266
Open AccessAssociations between Metabolic Syndrome Indicators and Colon Polyps: A Mendelian Randomization Study
Background: While observational studies have suggested a potential link between metabolic syndrome (MetS) and an increased risk of colon polyps, the causal nature of this association remains uncertain. This study used a two-sample Mendelian randomization (MR) approach to evaluate the relationship between MetS and colon polyps.Methods: A two-sample MR analysis was performed using data on MetS, its indicators, and colon polyps obtained from publicly available genome-wide association studies in the Integrative Epidemiology Unit (IEU) and MAGIC databases. Outliers were removed using Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), followed by MR calculations and false discovery rate (FDR) correction. The primary analysis was conducted with the inverse variance-weighted (IVW) method.Results: The IVW results indicated no association between hypertension, hyperlipidemia, or diabetes and the risk of colon polyps. High-density lipoprotein cholesterol (HDL-C) (P=0.005), 2-hour glucose (P=0.004), glycated hemoglobin A1c (P=0.004), and the ratio of omega-6 to omega-3 fatty acids (P<0.001) were negatively associated with colon polyps. Conversely, body mass index (BMI) (P<0.001), body fat percentage (P=0.002), waist-to-hip ratio adjusted for BMI (P=0.001), total cholesterol (TC) (P=0.002), triglycerides (TG) (P<0.001), and both omega-3 (P<0.001) and omega-6 fatty acid levels (P=0.02) were positively associated with colon polyps. The relationships between these metabolic indicators and colon polyps remained significant after FDR correction.Conclusion: Obesity-related traits, TC, and TG may increase the risk of colon polyps, while HDL-C may have a protective effect.
- Open Access
- 11 March 2022
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 31 (6) , 623-633
The influence of mosapride on gut microbiota of carbon tetrachloride-induced cirrhosis rats based on 16S rRNA gene sequencing
Mosapride significantly improves intestinal motility in liver cirrhosis, ultimately leading to the reduction in plasma endotoxin levels and bacterial translocation. To investigate the effects of mosapride on intestinal microecology in cirrhotic rats and its potential mechanisms. Forty-five healthy male Sprague-Dawley rats that were pathogen-free (weight 200-220 g) were randomly divided into a control group (n = 15), model group (n = 15) and mosapride group (n = 15). Then, the pathological changes in the liver and intestine were determined through tissue staining and using transmission electron microscope (TEM). Bacterial translocation was examined. High throughput 16S rRNA sequencing was performed to determine the changes of gut microbiota in each group. Compared with the model group, mosapride treatment induced no attenuation in hepatic morphology and pathology changes. The TEM indicated no differences in intestinal structure in both groups. There was a significant decline in the rate of gut microbiota translocation in the mosapride group compared with the model group. There were intestinal microbiota changes in the mosapride group compared with that of the model group, including Bacteroidetes, Prevotellaceae, Alloprevotella, Ruminiclostridium, Negativicutes, Selenomonadales, Veillonellaceae, Anaerovibrio, Campylobacterales, Epsilonbacteraeota, Helicobacter, Oscillibacter, Verrucomicrobiales, Akkermansia, Intestinimonas, Eubacterium, Clostridiaceae, Clostridium, Bacteroides, Tyzzerella, Actinobacteria, and Bifidobacteriales. Among these bacteria, Alloprevotella showed a strong correlation with the other bacteria. Taken together, we concluded that mosapride may reduce intestinal bacterial translocation through regulating the gut microbiota in rats with hepatic cirrhosis.
- 11 March 2022
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 31 (6) , 623-633
Open AccessThe influence of mosapride on gut microbiota of carbon tetrachloride-induced cirrhosis rats based on 16S rRNA gene sequencing
Mosapride significantly improves intestinal motility in liver cirrhosis, ultimately leading to the reduction in plasma endotoxin levels and bacterial translocation. To investigate the effects of mosapride on intestinal microecology in cirrhotic rats and its potential mechanisms. Forty-five healthy male Sprague-Dawley rats that were pathogen-free (weight 200-220 g) were randomly divided into a control group (n = 15), model group (n = 15) and mosapride group (n = 15). Then, the pathological changes in the liver and intestine were determined through tissue staining and using transmission electron microscope (TEM). Bacterial translocation was examined. High throughput 16S rRNA sequencing was performed to determine the changes of gut microbiota in each group. Compared with the model group, mosapride treatment induced no attenuation in hepatic morphology and pathology changes. The TEM indicated no differences in intestinal structure in both groups. There was a significant decline in the rate of gut microbiota translocation in the mosapride group compared with the model group. There were intestinal microbiota changes in the mosapride group compared with that of the model group, including Bacteroidetes, Prevotellaceae, Alloprevotella, Ruminiclostridium, Negativicutes, Selenomonadales, Veillonellaceae, Anaerovibrio, Campylobacterales, Epsilonbacteraeota, Helicobacter, Oscillibacter, Verrucomicrobiales, Akkermansia, Intestinimonas, Eubacterium, Clostridiaceae, Clostridium, Bacteroides, Tyzzerella, Actinobacteria, and Bifidobacteriales. Among these bacteria, Alloprevotella showed a strong correlation with the other bacteria. Taken together, we concluded that mosapride may reduce intestinal bacterial translocation through regulating the gut microbiota in rats with hepatic cirrhosis.